Progress against lung cancer, Denmark, 2008-2022.

Area of Science:

• Oncology
• Public Health
• Epidemiology

Background:

• Denmark has observed significant progress in combating lung cancer.
• Understanding the drivers of these improvements is crucial for future strategies.

Purpose of the Study:

• To investigate stage-specific incidence, survival, and mortality rates for lung cancer in Denmark.
• To analyze trends and identify factors contributing to improved lung cancer outcomes.

Main Methods:

• Utilized data from the Danish Lung Cancer Registry for diagnosis dates and clinical staging.
• Calculated age-standardised incidence and survival rates by sex, period, and stage.
• Extracted lung cancer-specific mortality data from The Danish Health Data Authority.

Main Results:

• Incidence rates decreased, primarily due to a reduction in advanced-stage diagnoses.
• Patient survival rates showed a gradual increase across all disease stages.
• Age-standardised lung cancer-specific mortality rates steadily declined over the study period.

Conclusions:

• Improvements in lung cancer survival and mortality are attributed to reduced incidence of advanced disease.
• Enhanced survival rates across all stages of lung cancer contribute to better patient outcomes.
• The findings highlight the effectiveness of current strategies and inform future public health interventions.